Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomooka

Showing results (341-350 of 358) with videos related to

Pageof 36
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.
Digestive Diseases and Sciences|January 20, 2024
VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in CirrhosisShohei Asada, Tadashi Namisaki, Kosuke Kaji, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 13, 2023
Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitisYukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, et al.
International Journal of Molecular Sciences|May 14, 2025
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver CirrhosisTakuya Matsuda, Tadashi Namisaki, Akihiko Shibamoto, et al.
Digestive Diseases and Sciences|March 12, 2025
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular CarcinomaYuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, et al.
Journal of the American Chemical Society|January 10, 2024
Linkage-Editing Pseudo-Glycans: A Reductive α-Fluorovinyl-<i>C</i>-Glycosylation Strategy to Create Glycan Analogs with Altered Biological ActivitiesTakahiro Moriyama, Makoto Yoritate, Naoki Kato, et al.
In Vivo (Athens, Greece)|April 27, 2023
Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in JapanNobuyuki Yorioka, Tadashi Namisaki, Akihiko Shibamoto, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Pageof 36

Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.
Digestive Diseases and Sciences|January 20, 2024
VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in CirrhosisShohei Asada, Tadashi Namisaki, Kosuke Kaji, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 13, 2023
Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitisYukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, et al.
International Journal of Molecular Sciences|May 14, 2025
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver CirrhosisTakuya Matsuda, Tadashi Namisaki, Akihiko Shibamoto, et al.
Digestive Diseases and Sciences|March 12, 2025
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular CarcinomaYuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, et al.
Journal of the American Chemical Society|January 10, 2024
Linkage-Editing Pseudo-Glycans: A Reductive α-Fluorovinyl-<i>C</i>-Glycosylation Strategy to Create Glycan Analogs with Altered Biological ActivitiesTakahiro Moriyama, Makoto Yoritate, Naoki Kato, et al.
In Vivo (Athens, Greece)|April 27, 2023
Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in JapanNobuyuki Yorioka, Tadashi Namisaki, Akihiko Shibamoto, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Pageof 36